Abstract

Veralto Corporation will release fiscal first-quarter 2026 results on April 28, 2026 Post Market; consensus points to revenue of 1.40 billion US dollars and adjusted EPS of 1.01, while recent analyst commentary skews bullish and the company’s full‑year guidance and tuck‑in software acquisition frame a constructive near‑term setup.

Market Forecast

Based on the latest aggregated forecasts, Veralto Corporation’s current quarter is projected to deliver revenue of 1.40 billion US dollars, up 9.30% year over year, EBIT of 342.54 million US dollars, up 10.87% year over year, and adjusted EPS of 1.01, up 15.74% year over year. Margin guidance for the quarter is not explicitly available in the forecast dataset; the prior quarter’s gross profit margin was 59.31% and net profit margin was 18.19%, which provide a reference point for assessing the upcoming print. The company’s core mix remains stable with Water Quality and Product Quality & Innovation as the two primary pillars; consensus implies a mid‑to‑high single‑digit revenue growth path supported by price discipline and incremental software contribution. Most promising near‑term contribution is expected from packaging and coding software within Product Quality & Innovation, which generated 550.00 million US dollars last quarter and is supported by recent software expansion; at the company level, revenue is projected to grow 9.30% year over year this quarter.

Last Quarter Review

In the fourth quarter of 2025, Veralto Corporation reported revenue of 1.40 billion US dollars (+3.79% year over year), a gross profit margin of 59.31%, GAAP net income attributable to the parent of 254.00 million US dollars, a net profit margin of 18.19%, and adjusted EPS of 1.04 (+9.47% year over year). A notable highlight was the combination of disciplined execution and price realization that kept margins resilient while adjusted EPS of 1.04 exceeded the quarter’s consensus baseline; net profit improved quarter on quarter by 6.28%. By business line, Water Quality contributed 846.00 million US dollars and Product Quality & Innovation contributed 550.00 million US dollars, together supporting the 3.79% year‑over‑year top‑line increase and a healthy earnings conversion profile.

Current Quarter Outlook

Main business outlook

For fiscal Q1 2026, the market expects Veralto Corporation to post revenue of 1.40 billion US dollars, up 9.30% year over year, and adjusted EPS of 1.01, up 15.74% year over year, with EBIT estimated at 342.54 million US dollars, up 10.87% year over year. The spread between expected revenue and EPS growth implies incremental operating leverage and mix benefits, consistent with the company’s recent emphasis on recurring, software‑enabled offerings and ongoing price/cost management. While explicit gross and net margin forecasts are not enumerated in the consensus dataset, the prior quarter’s gross margin of 59.31% and net margin of 18.19% establish a solid base; any upside surprise on conversion would be reflected in outperformance on EPS versus revenue. Operationally, investors will watch the balance between price and volume and the flow‑through of productivity programs to EBIT. The sequential pattern from Q4 to Q1 can include normal seasonal activity in customer spend, but the year‑over‑year expansion in the revenue estimate suggests that demand and pricing remain constructive against last year’s comparable. With EBIT forecast at 342.54 million US dollars, the incremental margin implied by estimates aligns with a scenario where mix and cost actions offset normal start‑of‑year expense resets. Cash generation and orders commentary will also be consequential for how the market reassesses the full‑year trajectory. The company’s recently reaffirmed full‑year adjusted EPS framework of 4.10 to 4.20 suggests confidence in both growth durability and cost visibility; translating that to the quarterly cadence, execution in Q1 serves as an early proof point for margin structure and the ability to reinvest behind growth initiatives while preserving earnings expansion ahead of revenue.

Most promising business outlook

Within the current setup, Product Quality & Innovation stands out as an area of potential incremental contribution, particularly given the announced agreement to acquire GlobalVision, an AI‑enabled software provider for packaging accuracy and regulatory compliance slated to integrate into Esko. While the acquisition is expected to be neutral to adjusted earnings in 2026 and accretive in 2027, the strategic fit broadens the software and workflow footprint that underpins recurring revenue and strengthens the value proposition for enterprise packaging customers. This complements the established installed base and can support sustained pricing power and attach rates over time. Last quarter, Product Quality & Innovation delivered 550.00 million US dollars of revenue, offering a sizable base from which software‑driven workflows, compliance, and coding solutions can scale. For the current quarter, the 9.30% company‑level year‑over‑year top‑line growth expectation, combined with faster EPS growth, is consistent with higher‑margin mix that software expansion tends to support. As customers intensify focus on compliance and traceability within packaging, additional modules and analytics can drive incremental bookings, uplift maintenance and subscription revenue, and increase customer lifetime value, translating into improved operating leverage in the segment. Beyond software, hardware refresh cycles and consumables in coding and marking can provide steady demand under a broad set of operating conditions. In aggregate, the segment’s diversified revenue streams and the tuck‑in software expansion may help smooth quarterly variability, reinforcing the case for mid‑term margin resiliency and making this business a meaningful contributor to any upside versus the current 1.01 adjusted EPS expectation.

Key stock price drivers this quarter

The first determinant for the stock reaction will be the relationship between reported adjusted EPS and the 1.01 consensus, given the implied operating leverage embedded in forecasts. A clean beat on EPS alongside in‑line or better revenue typically signals stronger margin execution—either via mix, price realization, or cost productivity—and tends to be rewarded. Conversely, any shortfall on conversion would raise questions about cost timing or mix, and could prompt recalibration of the full‑year 4.10 to 4.20 adjusted EPS frame. A second driver will be commentary on order momentum and backlog across the company’s key solution areas. Investors will focus on book‑to‑bill trends, renewal rates, and software attach, as these indicators help validate the 9.30% revenue growth outlook for the quarter and inform the path for the second half. Positive qualitative cues—such as stable customer spending plans, healthy funnel progression, and evidence of cross‑sell between hardware and software—would support the bull case for continued outperformance in EPS growth relative to revenue growth. A third driver is the integration roadmap and commercial plans tied to the GlobalVision acquisition. Management’s articulation of integration milestones, go‑to‑market synergies with Esko, and early customer interest can frame expectations for 2027 accretion and near‑term revenue contribution, even if limited in 2026. Clarity on the capital allocation stance—balancing tuck‑in M&A, organic R&D, and shareholder returns—will help investors judge the durability of margin expansion and the scalability of the software platform that underlies the consensus EBIT growth of 10.87% this quarter.

Analyst Opinions

The aggregate of recent published opinions skews bullish, with multiple Buy/Outperform views outweighing neutral stances and no material bearish calls in the period. Jefferies assumed coverage with a Buy rating in late March, highlighting the durability of earnings and the early‑stage opportunity in software and compliance solutions that enhance visibility and quality across customer workflows. Wolfe Research maintained an Outperform rating in April, emphasizing execution consistency and a balanced growth algorithm that combines organic expansion with disciplined portfolio shaping; even as the firm reduced its price target to 103.00 US dollars, it reaffirmed confidence in the earnings trajectory underpinning the current consensus. Argus reiterated a Buy rating in February with a 110.00 US‑dollar price target, pointing to the company’s ability to expand margins through pricing, productivity, and mix, which aligns with the forecast for adjusted EPS growth of 15.74% against 9.30% revenue growth this quarter. The firm also flagged the merits of software integration and recurring revenue in shaping a smoother earnings profile across cycles. While some institutions maintained neutral stances, the bullish cohort argues that the improved quality of earnings—supported by recurring software, aftermarket, and disciplined pricing—justifies a constructive stance into the April 28, 2026 print. From a near‑term perspective, the bullish view centers on three points. First, consensus modeling already embeds prudent assumptions on revenue, yet the EBIT estimate of 342.54 million US dollars and the 1.01 adjusted EPS leave room for upside if execution on price/cost and mix aligns with recent trends. Second, the strategic layering of software, as evidenced by the GlobalVision acquisition for Esko, strengthens the company’s ability to deliver faster EPS growth relative to revenue growth, a dynamic that is explicitly reflected in this quarter’s projections. Third, the company’s full‑year adjusted EPS framework of 4.10 to 4.20 provides a credible anchor for 2026, allowing investors to benchmark quarterly progress without relying on aggressive top‑line assumptions. On balance, the dominant analyst narrative is that Veralto Corporation enters the quarter with a defensible margin base (59.31% gross, 18.19% net in Q4 2025) and a path to incremental leverage as software and services scale. If the company validates the 9.30% revenue and 15.74% adjusted EPS growth expectations with clean execution and constructive order commentary, the bullish case anticipates positive estimate revisions and a favorable stock reaction, consistent with the majority of recent Buy and Outperform ratings.